INSIGHTS ON REGULATORY COMPLIANCE
-
![WestPFS]( "Demystifying Performance Testing: Strategies To Qualify Combination Products")
Demystifying Performance Testing: Strategies To Qualify Combination ProductsDemonstration of fit-for-purpose for a drug-device combination product requires demonstration of system performance that meets regulatory requirements. This article presents a best practice strategy for performance testing. It starts with a thorough understanding of applicable regulations and guidances. Following this, performance risks are identified using failure modes and effects analyses (FMEA) and failure cause mapping analyses. Next, a test plan based on accepted standards is designed and executed, considering highest risk failure modes first.
-
![Pharma Lab Worker]( "Downstream Processing Of Biosimilars: Evolving Challenges And Considerations")
Downstream Processing Of Biosimilars: Evolving Challenges And ConsiderationsFuture evolutions in the biosimilar regulatory pathway will require biosimilar manufacturers to ask several critical questions about the implementation of legacy and novel technologies and procedures in downstream processing.
-
![Scientist laboratory research drug discovery]( "Best Practices for 21 CFR Part 11 And GxP Validation For Electronic Records")
Best Practices for 21 CFR Part 11 And GxP Validation For Electronic RecordsDrug development has dramatically changed over the past ten years. A practice once dominated by pen-and-paper has since transitioned to computerized systems, cloud software, and artificial intelligence. This paper chronicles recent technological trends, specific challenges these trends pose for Quality & CSV teams, and best practices for tackling resulting compliance issues.
-
![Egnyte 2]( "Using Egnyte For Life Sciences As GxP Repository")
Using Egnyte For Life Sciences As GxP RepositoryTransitioning from the research phase to the clinical trial phase is a big step for any company, but it also means challenges, not the least of which means your electronic records need to comply with FDA 21 CFR Part 11 and GxP. In this democast, we will review how to deploy and use a GxP-compliant repository using Egnyte’s industry-focused platform, Egnyte for Life Sciences, without sacrificing usability or security, and without creating administrative overhead.
-
How To Stay Ahead Of Disruptive Trends In Clinical Trials
Clinical trials are evolving. Whether it’s disruptive technology, changing regulations, or external factors. The pace of change is only increasing - along with the complexity of ensuring your trial data is secure and compliant. This session will provide best practices and insight into how to keep pace with the changes and be better prepared for what’s still to come.
-
Raman Spectroscopy Beyond The Lab: From Loading Dock To Production
Raman spectroscopy offers a wide range of benefits in industrial and academic research, helping drive profitability in development, research, and quality control.
-
3 Ways To Mitigate Data Manipulation Risk In Drug Development
A critical output of the drug development process, besides the compound itself, is data. We highlight specific actions to mitigate your organization’s risk of data manipulation and three key steps in tackling this problem.
-
Process Characterization And Validation For Biologic Processes
Using a risk-based approach to generate an appropriate control strategy will help assure your product meets characterization and validation requirements, enabling timely approval and launch to market.
-
Automating Cell Therapy Manufacturing For GMP Compliance And Consistency
Exploring the use of automation in cell therapy and advanced therapeutic medicinal product manufacturing to improve safety, quality, and compliance is a key factor in advancing patient care.
REGULATORY COMPLIANCE SOLUTIONS
-
![EZBiopac]( "Powder Transfer Process")
Powder Transfer ProcessEZ BioPac is meeting the challenges of biopharmaceutical powder manufacture. The EZ BioPac single-use system is the fastest, most efficient solution. Its larger diameter top opening permits easy filling and fine-tuning of final weight.
-
![Capsule]( "FD&C 503B")
FD&C 503BInnovative therapies including customized, patient-specific compounds, are transforming healthcare, and presenting new challenges for pharmaceutical development, manufacturing, and supply chain management. Our healthcare ecosystem is experiencing tectonic shifts and providing a reliable supply of safe and effective medicines for hospitals and clinics to use for their patients will require an innovative, problem-solving mindset. The experienced scientists, engineers, and staff at Pii pride themselves in solving challenging problems, it is part of our DNA.
-
![CAI]( "Pharmaceutical Asset Management & Reliability Services")
Pharmaceutical Asset Management & Reliability ServicesAsset Management & Reliability (AMR) focuses on preserving asset functions. These functions are determined by our clients’ business strategy. The focus is on producing products that conform to consumer needs in the most efficient and cost-effective manner. While conditions vary, the common factor with manufacturing process is reliability. We help our clients determine which best practices are applicable in your industry and how best to deploy them.
-
![CAI]( "Quality, Compliance, And Regulatory Services For Life Sciences")
Quality, Compliance, And Regulatory Services For Life SciencesThe biotechnology, medical device, and pharmaceutical industries are highly regulated globally by a diverse group of agencies. Assuring GMP Quality and Regulatory Compliance throughout your supply chain is a challenge. Meeting this challenge requires a successful interaction between knowledge, systems, and people.
-
GxP Document Management For Life Sciences Guide
Choosing the right document management platform comes with daunting responsibility: compliance, usability, and adoption to name a few. We created this Buyer’s Guide to provide you with a tangible framework to evaluate varied solutions and, ultimately, identify one or more that meet your specific use case.
